SCHEMBL4461522

SCHEMBL4461522

Cc1cccc2c1Oc1ccc(C(F)F)cc1N=C2N1CCNCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.48
HTR2A P28223 5/20 0.46
ADRA2A P08913 4/20 0.46
HTR1A P08908 3/20 0.46
DRD2 P14416 6/20 0.44
HTR2C P28335 3/20 0.44
CYP1A2 P05177 3/20 0.44
CHRM2 P08172 3/20 0.44
CHRM4 P08173 3/20 0.44
CHRM5 P08912 3/20 0.44
CHRM1 P11229 3/20 0.44
CHRM3 P20309 3/20 0.44
DRD1 P21728 3/20 0.44
KCNH2 Q12809 3/20 0.44
HTR7 P34969 3/20 0.44
DRD4 P21917 3/20 0.44
ADRA2B P18089 2/20 0.44
ADRA2C P18825 2/20 0.44
ADRA1D P25100 2/20 0.44
ADRA1A P35348 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3414295 0.86 HRH4 (0.53) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL3408025 0.86 HTR1A (0.50) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL3407418 0.84 ADRA2A (0.49) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL3411774 0.84 ADRA2A (0.48) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL3408030 0.84 HTR2A (0.65) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL3407775 0.82 DRD2 (0.57) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL3411352 0.79 HRH4 (0.64) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL23242587 0.75 DRD2 (0.60) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL5326459 0.74 HTR7 (0.45) HRH4HTR2AADRA2AHTR1ADRD2
SCHEMBL7414308 0.72 HRH4 (0.82) HRH4HTR2AADRA2AHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2088147-A1 Dibenzo-condensed azepine, diazepine, oxazepine and thiazepine derivatives as muscarinic agonists and methods of treatment of neuropsychiatric disorders Arcadia Pharmaceuticals Inc. (US) 2009-08-12 EP disclosed